15-78596058-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000743.5(CHRNA3):c.*546C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.309 in 980,552 control chromosomes in the GnomAD database, including 51,406 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 13877 hom., cov: 32)
Exomes 𝑓: 0.29 ( 37529 hom. )
Consequence
CHRNA3
NM_000743.5 3_prime_UTR
NM_000743.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.269
Publications
180 publications found
Genes affected
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
- urinary bladder, atony ofInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.765 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNA3 | NM_000743.5 | c.*546C>T | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000326828.6 | NP_000734.2 | ||
| CHRNA3 | XM_006720382.4 | c.*546C>T | 3_prime_UTR_variant | Exon 6 of 6 | XP_006720445.1 | |||
| CHRNA3 | NM_001166694.2 | c.1390-2867C>T | intron_variant | Intron 5 of 5 | NP_001160166.1 | |||
| CHRNA3 | NR_046313.2 | n.1784+482C>T | intron_variant | Intron 6 of 7 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRNA3 | ENST00000326828.6 | c.*546C>T | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_000743.5 | ENSP00000315602.5 | |||
| CHRNA3 | ENST00000348639.7 | c.1390-2867C>T | intron_variant | Intron 5 of 5 | 1 | ENSP00000267951.4 | ||||
| CHRNA3 | ENST00000559002.5 | n.193+482C>T | intron_variant | Intron 1 of 1 | 1 | |||||
| CHRNA3 | ENST00000559658.5 | n.*64+482C>T | intron_variant | Intron 6 of 7 | 2 | ENSP00000452896.1 |
Frequencies
GnomAD3 genomes AF: 0.399 AC: 60651AN: 151952Hom.: 13846 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
60651
AN:
151952
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.293 AC: 242706AN: 828482Hom.: 37529 Cov.: 21 AF XY: 0.292 AC XY: 111870AN XY: 382700 show subpopulations
GnomAD4 exome
AF:
AC:
242706
AN:
828482
Hom.:
Cov.:
21
AF XY:
AC XY:
111870
AN XY:
382700
show subpopulations
African (AFR)
AF:
AC:
8820
AN:
15646
American (AMR)
AF:
AC:
581
AN:
982
Ashkenazi Jewish (ASJ)
AF:
AC:
1315
AN:
5126
East Asian (EAS)
AF:
AC:
2863
AN:
3594
South Asian (SAS)
AF:
AC:
7401
AN:
16352
European-Finnish (FIN)
AF:
AC:
95
AN:
276
Middle Eastern (MID)
AF:
AC:
556
AN:
1600
European-Non Finnish (NFE)
AF:
AC:
211765
AN:
757790
Other (OTH)
AF:
AC:
9310
AN:
27116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
7215
14430
21645
28860
36075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9824
19648
29472
39296
49120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.399 AC: 60734AN: 152070Hom.: 13877 Cov.: 32 AF XY: 0.406 AC XY: 30156AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
60734
AN:
152070
Hom.:
Cov.:
32
AF XY:
AC XY:
30156
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
22328
AN:
41464
American (AMR)
AF:
AC:
8049
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
925
AN:
3468
East Asian (EAS)
AF:
AC:
4064
AN:
5174
South Asian (SAS)
AF:
AC:
2264
AN:
4824
European-Finnish (FIN)
AF:
AC:
3392
AN:
10576
Middle Eastern (MID)
AF:
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18619
AN:
67950
Other (OTH)
AF:
AC:
829
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1722
3444
5165
6887
8609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2161
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.